Literature DB >> 1159911

Mitomycin C bladder instillation therapy for bladder tumors.

T Mishina, K Oda, S Murata, H Ooe, Y Mori.   

Abstract

Patients with bladder tumors underwent a course of topical bladder instillation of 20 mg. mitomycin C in 20 ml. sterilized distilled water 3 times weekly for a total of 20 procedures. In 22 of the 50 patients (44 per cent) the tumors disappeared completely, while in 16 patients (32 per cent) there was partial disappearance and in 12 patients (24 per cent) there was no affect. Therefore, the total effective rate was 76 per cent. We concluded from our studies that mitomycin C topical therapy could be applied to low stage and low grade bladder tumors less than 1 cm. in diameter, without regard to the number of tumors. We now use mitomycin C topical therapy in all cases of bladder tumors. Local bladder reaction was noted in 3 cases but a complete course of therapy was accomplished in each case--in 2 cases without interruption of treatment and in 1 case by delaying treatment for 1 week. Abnormal values of hematocrit, white blood cells and platelets in blood were not observed during therapy.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1159911     DOI: 10.1016/s0022-5347(17)66989-1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  23 in total

1.  Denudation of the urinary bladder mucosa in the cat by formaldehyde.

Authors:  R Pust; M Butz; A Rost; S Ogbuihi; B Riedel
Journal:  Urol Res       Date:  1976-07-23

2.  Size and location of tumors influencing the effect of bladder instillation therapy.

Authors:  H Watanabe; M Nakao; S Nakagawa; H Takada
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

3.  Validation of an HPLC-MS/MS and wipe procedure for mitomycin C contamination.

Authors:  Clayton B'Hymer; Thomas Connor; Derek Stinson; Jack Pretty
Journal:  J Chromatogr Sci       Date:  2014-08-16       Impact factor: 1.618

Review 4.  Superficial bladder cancer: state of the art.

Authors:  A V Bono
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 5.  Intravesical chemotherapy in the United States. An overview.

Authors:  J T Spaulding
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

6.  Dermatitis due to mitomycin bladder instillations.

Authors:  V S Neild; K V Sanderson; P R Riddle
Journal:  J R Soc Med       Date:  1984-07       Impact factor: 5.344

7.  Comparison of 30 mg and 40 mg of mitomycin C intravesical instillation in Korean superficial bladder cancer patients: prospective, randomized study.

Authors:  Chang Wook Jeong; Hwang Gyun Jeon; Cheol Kwak; Hyeon Jeong; Sang Eun Lee
Journal:  Cancer Res Treat       Date:  2005-02-28       Impact factor: 4.679

8.  Intravesical adriamycin chemotherapy in bladder cancer.

Authors:  Y Matsumura; Y Ozaki; H Ohmori
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

9.  Randomized clinical trial on chemoprophylaxis of recurrence in cases of superficial bladder cancer.

Authors:  T Niijima; K Koiso; H Akaza
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

10.  Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party).

Authors:  D A Tolley; T B Hargreave; P H Smith; J L Williams; K M Grigor; M K Parmar; L S Freedman; B M Uscinska
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.